KATHLEEN PEARL: Open Payments
NPI 1851392344 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 10 payments from 4 companies in 2025. Trend: 2023 $1,699 · 2024 $846 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $149 |
| Novartis Pharmaceuticals Corporation | 4 | $70 |
| GENZYME CORPORATION | 3 | $62 |
| Cumberland Pharmaceuticals, Inc. | 1 | $19 |
Products named: Fabhalta, SARCLISA, CALQUENCE, SANCUSO.
Industry payments across NJ — which companies pay providers there.
